4-Bromo-5-((4-hydroxyphenethylamino)methyl)-2-methoxyphenol, 98%, 100mg

(S)-(2-Oxooxazolidin-4-yl)methyl 4-methylbenzenesulfonate, 98%, 250mg

Adamantan-2-one oxime, 95.0%, 1g

Citrate de potassium monohydraté 99+% 1 g

2-Amino-4-methylphenol, 99.00%, 25g

4-Methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 5g

N-Benzyloxycarbonyl-L-serine>98.0%(HPLC)(T)5g

N'-((Dimethylamino)methylene)-N,N-dimethylformohydrazonamide, 95.0%, 25g

(S)-2-Hydroxybutyric acid, 95.0%, 5g

(11bS)-3,5-Bis(2,2-dimethylbutyl)-4,5-dihydro-3H-dinaphtho[2,1-d:1',2'-f][1,3,2]diazaphosphepine 4-oxide, 98%, 50mg

1-BROMOMETHYL-4-ISOPROPYLBENZENE, 95%, 1g

4-CHLORO-6-(2,2,2-TRIFLUOROETHOXY)PYRIMIDINE, 95.0%, 100mg

Hexacyanoferrate(II) de potassium trihydraté, min 98,5 %, cristallisé, 5 kg, emballage plastique.